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The epidermal growth factor (EGF) from the submaxillary glands of the Chinese Shrew (Suncus murinus) 
is purified to apparent homogeneity by using a sequence of four chromatographic steps, viz. gel filtration 
on Sephacryl S-200, aflinity chromatography on immobilized Ni, hydrophobic interaction on phenyl- 
Sepharose CL4B and reverse-phase HPLC. An 800-fold increase in specific activity and an overal recovery 
of 46% were achieved. The most effective step in its purification is the successful use of immobilized metal 
ion affinity chromatography (IMAC). This method was very selective, reproducible and requires aminimum 
of sample pre-treatment prior to chromatography. 
Shrew EGF Immobilized metal ion affinity chromatography Radioreceptor assay 
1. INTRODUCTION 
The original method used in the purification of 
mouse epidermal growth factor (EGF) involved 
multiple and lengthy steps [l]. The method was 
later modified and the use of Biogel and DEAE- 
cellulose chromatography [2], reverse-phase 
HPLC [3] and high-resolution ion-exchange 
chromatography [4] gave much better results. 
However, a more efficient method for the purifica- 
tion of EGF is needed, especially when the highest 
possible purity is required for detailed studies of 
the biological and chemical properties of the 
isolated EGF. 
The shrew (Suncus murkus) submaxillary gland 
is a rich source of EGF according to our investiga- 
tions (Yip et al., to be published). Although EGF 
from several other species have been reported, the 
EGF from the shrew has not been studied until 
now. Here, its isolation from a crude extract of the 
Abbreviations: Ni-TED, Ni2+ immobilized on tricarbox- 
ymethylethylenediamine (TED) covalently linked to 
Sepharose 6B; IMAC, immobilized metal ion affinity 
chromatography 
submaxillary gland by using a sequence of 4 
chromatographic procedures is described. 
2. MATERIALS AND METHODS 
Shrews were captured from the wild. Their sub- 
maxillary glands were excised, rinsed with distilled 
water, blotted dry, and immediately frozen. 1 g of 
the glands (wet wt) was added to 9 ml cold distilled 
water containing 5 mM phenylmethylsulfonyl 
fluoride and homogenized in a Polytron PT 45-50 
at maximum speed for 30 s. The homogenate was 
centrifuged at 40000 x g for 50 min. This pro- 
cedure was repeated twice on the pellet. The super- 
natants were combined and lyophilized. 
Standard mouse EGF preparations were ob- 
tained from Collaborative Research. Iodination 
was carried out according to the standardized 
chloramine T method. The radioreceptor assay 
(RRA) for EGF was performed according to the 
method of Imai et al. [5]. The standard binding 
curve was usable in the range 0.1-20 ng EGF. The 
shrew EGF preparations gave binding curves that 
were identical to the standard throughout the en- 
tire range. 
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Sephacryl S-200, phenyl-Sepharose CL4B, and 
Sepharose 6B were products of Pharmacia, Upp- 
sala. The metal chelating gel (tricarboxymethyl- 
ethylenediamine, TED, coupled to Sepharose 6B) 
was synthesized according to the method of Porath 
and Olin [6]. HPLC was carried out on an LDC 
Constametic IIG system. The column (4 x 
250 mm) was packed with Lichrosorb RP-18 (5 ym 
beads) obtained from Merck AC, FRG. 
3. RESULTS AND DISCUSSION 
Fig.1 shows the fractionation obtained after 
chromatography of the crude extract from the 
shrew submaxillary gland on Sephacryl S-200. The 
major components, which are inactive, are eluted 
near the void volume of the column. The activity 
peak is associated with the minor components that 
elute between fractions 40 and 50 with an apparent 
M, between those of hemoglobin and cytochrome 
c. The recovery of applied material was about 
90%) while the recovery in activity was about 65% 
in the pooled fractions. 
The active material was pooled and &SO4 was 
dissolved in it to a final concentration of 0.5 M. 
This was then applied to an Ni-TED column and 
the fractionation obtained is shown in fig.2. About 
FRACTON 
Fig. 1. Gel filtration of the crude extract from the shrew 
submaxillary glands on a column (3.2 x 130 cm) of 
Sephacryl S-200. The column was equilibrated and 
eluted with 50 mM Tris-HCl buffer, pH 7.4. The flow 
rate was 10.7 mlecm-* . h-’ and fractions of 20 ml were 
collected. (M) Absorbance at 280 nm, (ti) 
concentration of EGF &g/fraction) determined by RRA 
on a 30-fold dilution of each fraction. The horizontal 
bar at the top shows the fractions that were pooled. Hb 
and Cyt c, elution positions of hemoglobin and 
cytochrome c, respectively. 
FRACTON 
Fig.2. IMAC of the activity pool from fig. 1 on Ni-TED. 
The column (2 x 15 cm) was equilibrated with 50 mM 
Tris-HCl buffer, 0.5 M in KzSO~, pH 7.4, and 
maintained at a flow rate of 23 ml. cm-*. h-l. Solid 
K2S04 was dissolved in the pooled sample to give a final 
concentration of 0.5 M prior to application to the 
column. Unadsorbed material was washed out with 
equilibrating buffer and the adsorbed, active material 
was eluted by 0.1 M Na acetate buffer, 0.5 M in KzS04, 
pH 6.0. (o----o) Absorbance at 280 nm, (ti) 
concentration of EGF &g/fraction). Pooled fractions 
are indicated by the horizontal bar. 
70% of inactive material was eluted unadsorbed 
from the column. The active material, adsorbed to 
the column, was recovered almost quantitatively 
(table 1) by elution with 0.1 M sodium acetate buf- 
fer, 0.5 M in R2S04, pH 6.0. However, the activity 
peak did not correspond well with the protein 
peak, indicating heterogeneity and the necessity 
for further purification. The total recovery of ap- 
plied material or activity was better than 90%. By 
this step alone, the active material was purified by 
a factor of about 18 as estimated from its specific 
activity (table 1). 
The active pool from the previous step was 
purified further by a factor of 3 after 
chromatography on phenyl-Sepharose CL-4B (see 
fig.3 and table 1). The activity was adsorbed and 
an attempt was made to elute it by decreasing the 
salt concentration in a linear gradient from 0.5 to 
0 M K2S04 in 0.1 M Na acetate, pH 6.0. The total 
gradient volume was about 1.5-times the total col- 
umn volume. However, most of the activity re- 
mained adsorbed to the column and was eluted by 
washing of the column with the 0.1 M Na acetate 
buffer, pH 6.0. Further material or activity was 
not eluted by washing the column with 60% 
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Table 1 
Summary of the purification scheme for shrew EGF 
Sample Total Total Protein EGF Specific Yield 
volume A280 (mg) old activity (Qo) 
(ml) 
Crude extract 
Sephacryl S-200 
pool 
Ni-TED pool 
Phenyl-Sepharose 
pool 
RP-HPLC pool 
70 1231 882 1080 1.22 100 
185 121 78.6 695 8.84 64.4 
100 7.6 4.0 650 163 60.2 
119 2.3 1.2 600 500 55.6 
1 0.4 0.5 500 1000 46.3 
ethylene glycol in the above acetate buffer. The 
recovery of applied material and activity was 
almost quantitative (table 1). 
The final purification of the EGF to apparent 
homogeneity was achieved by chromatography of 
the active pool from the previous step on a column 
of reverse-phase HPLC (fig.4). The active pool 
from the phenyl-Sepharose CL4B column was 
dialyzed against distilled water, lyophilized, and 
redissolved in 200~1 distilled water. Aliquots of 
50 ~1 were applied to the HPLC column, followed 
by elution with a linear gradient from 20 to 32% 
acetonitrile in 50 mM triethylammonium acetate 
buffer, pH 5.6. The flow rate was 0.5 ml/min and 
the total gradient time was 30 min. The activity 
Fig.3. Chromatography of the active pool from fig.2 on 
phenyl-Sepharose CL-4B. The column (2.5 x 15 cm) was 
equilibrated with the buffer used in fig.2 and the flow 
rate was maintained at 23 ml.cm-‘. h-l. Fractions of 
7 ml were collected. The arrows at tubes 30 and 45 
indicate the start and end of the linear gradient. 
(M) Absorbance at 280 nm, (&--A) concentration 
of EGF &g/fraction). Horizontal bar indicates fractions 
that were pooled. 
was mainly confined to the major protein peak 
that emerged near the end of the gradient (as in- 
dicated by arrows in fig.4). A very minor activity 
peak was also eluted just after this main peak. 
When the major activity peak was pooled and 
rerun on a regenerated column under the same 
conditions as above (see inset in fig.4) only one 
symmetrical peak was eluted at a position cor- 
responding to that of the major peak A in fig.4 
showing the chromatographic homogeneity of this 
highly purified preparation. This material was very 
potent in biological assays such as enhancing eye- 
lid opening and in promoting mitogenesis of 
human fetal lung fibroblasts grown in vitro. Com- 
pared with the starting crude extract, this prepara- 
tion was at least 800-times more potent (table 1). 
The high overall yield of the active, purified 
material indicates the suitability and effectiveness 
of the procedure we adopted for purifying the 
shrew EGF. It could well be adopted for isolating 
EGFs from other sources, especially since the pro- 
cedures we employed were very reproducible and 
the whole purification step can be performed in 2 
or 3 days. 
Of the purification procedures we have used, 
that based on IMAC [6,7] was the most effective 
and the recovery in activity was almost quan- 
titative. The principles and basic mechanisms of 
this versatile method for protein fractionation 
have recently been published [6,8] and its 
usefulness is further extended by the results of 
Sulkowski et al. [9] which indicate the effectiveness 
of IMAC methods in assessing the topography of 
a protein molecule with respect o the accessibility 
of histidine and, possibly, tryptophan residues. 
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Fig.4. Final purification of the pooled active material from fig.3 on a reverse-phase HPLC column. One major peak 
(A), accounting for about 85% of the EGF activity and a minor peak (B) were separated. The inset shows the 
chromatographic homogeneity of the major peak after rerunning the pooled material in peak A on the same HPLC 
column, using a shallow gradient. 
The fact that the shrew EGF binds to the 
hydrophobic adsorbent, phenyl-Sepharose CL4B, 
might indicate structural similarities with EGFs 
from other species. The results of Holladay et al. 
[lo] indicate that mouse and human EGF have a 
high content of tyrosine residues, a large propor- 
tion of which are exposed indicating the 
hydrophobic nature of these proteins. Further 
studies on the purified shrew EGF are expected to 
elucidate in more detail its relationships to other 
known and well characterized EGFs. 
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